Cerebral Autoregulation and Vasospasm in Patients With TBI
1 other identifier
observational
25
1 country
1
Brief Summary
Traumatic brain injury (TBI) affects 1.5 million patients per year in the United States, resulting in more than 50,000 deaths and more than 230,000 hospitalizations annually. Approximately 90,000 of these patients will suffer permanent impairment and more than half will experience short-term disability. Secondary injury processes play a critical role in the development of ischemia after trauma to the central nervous system and occur hours-to-days after the primary insult. Ischemia can lead to cerebral infarction or stroke. Ischemia has been described as the single most important secondary insult and has been identified histologically in approximately 90% of patients who die following closed head injury. Several factors resulting in post-traumatic cerebral ischemia have been identified: increased intracranial pressure (ICP), systemic arterial hypotension, and cerebral vasospasm. Cerebral vasospasm has been described as a sustained arterial narrowing. Clinically, the onset of new or worsening neurological symptoms is the most reliable indicator of cerebral vasospasm following a ruptured cerebral aneurysm. However, cerebral vasospasm is often unrecognized in patients suffering from moderate to severe TBI. These patients frequently have altered mental status due to the primary brain injury. In addition, they require narcotics for their pain and paralytics and/or sedatives while on a mechanical ventilator for airway protection. Thus, relying on the neurological exam to observe deteriorating neurological signs consistent with post-traumatic vasospasm (PTV) is reliable. While the etiology and outcome of patients with vasospasm secondary to ruptured aneurysm is well documented, the clinical significance of PTV after TBI is unknown. A better understanding of the role of cerebral autoregulation in the development of cerebral vasospasm could provide the answer. This proposal is for a pilot observational study describing the association of the impairment of cerebral autoregulation as measured by near infrared spectroscopy (NIRS) with the development of clinically significant vasospasm in patients with moderate to severe TBI. The information will serve as preliminary data for further study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2015
CompletedFirst Posted
Study publicly available on registry
January 30, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2017
CompletedJanuary 27, 2022
January 1, 2022
1.7 years
January 19, 2015
January 26, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Functional Outcome as assessed by the Glasgow Functional Outcome-Extended
within 12 months post hospital discharge
Secondary Outcomes (2)
Mortality
within 30 days
Hospital Length of Stay
within 60 days
Interventions
There will be no interventions in this study
Eligibility Criteria
All patients aged 15 years and older, presenting with a motor score of \<6 and thought to have TBI due to a mechanism of injury, will undergo screening with head computed tomography (CT). Admission CT will be interpreted by an attending radiologist to determine Head Abbreviated Injury Score (AIS) score. If the AIS score by CT is \> 2, the patient will be eligible for the study. Patients determined by neurosurgery to have a non-survivable TBI on admission will be excluded given the poor likelihood of completion of the study protocol.
You may qualify if:
- years of age and greater
- Motor Glasgow Coma Score (GCS) \< 6 within approximately 24 hours of admission
- Head AIS \> 2
You may not qualify if:
- Motor GCS \>5
- Determination of non-survivability on admission
- Non-English speakers
- Prisoners that are on parole or probation
- Active duty military
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
R Adams Cowley Shock Trauma Center, University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Stein, MD, MPH
Professor of Surgery, Department of Surgery, Chief of Trauma R Adams Cowley Shock Trauma Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Surgery, University of Maryland , Chief of Trauma R Adams Cowley Shock Trauma Center
Study Record Dates
First Submitted
January 19, 2015
First Posted
January 30, 2015
Study Start
November 1, 2015
Primary Completion
June 30, 2017
Study Completion
June 30, 2017
Last Updated
January 27, 2022
Record last verified: 2022-01